LDE225 - Hedgehog Antagonist. CAS# 956697-53-3 size:2mg solid 26)27/h2-6

26)27/h2-6

Induction of more physiologically T-cell driven responses such as host vs

N-2-Biphenylyl-7-nitro-2

Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13

181(2):710-724

LDE225 - Hedgehog Antagonist. CAS# 956697-53-3 size:2mg solid 26)27/h2-6LDE225, CAS No. 956697 53 3, is a potent and specific Hedgehog pathway inhibitor through binding and antagonizing Smo with an IC50 of 11 nM. It is currently in the clinical trials to treat cancers. It inhibited Hh signaling and induces tumor regression in animal models of medulloblastoma. It sensitized chemotherapy resistant ovarian cancer cell lines to paclitaxel, but not to carboplatin. In one of the clinical trials, treatment with 0. 75% LDE225